重組蛋白
重組蛋白是解析生物相互作用的關(guān)鍵工具，廣泛應(yīng)用于各類研究實(shí)驗(yàn)中。無論是商業(yè)化產(chǎn)品，還是為特定研究定制的蛋白，它們都在多種科學(xué)應(yīng)用中發(fā)揮著不可替代的作用。
若您需要優(yōu)質(zhì)重組蛋白——已驗(yàn)證的生物活性、低內(nèi)毒素水平、高純度——來為您的研究提供可靠支持，這里正是您的理想之選。
歷經(jīng)18年積累，華美生物已構(gòu)建覆蓋原核與真核的五大蛋白質(zhì)表達(dá)系統(tǒng)。我們擁有包括桿狀病毒外膜蛋白（OMP）表達(dá)技術(shù)、膜蛋白表達(dá)技術(shù)等在內(nèi)的多項(xiàng)蛋白表達(dá)與純化專有技術(shù)，致力于為您提供高質(zhì)量的重組蛋白解決方案。
產(chǎn)品特點(diǎn)
- 覆蓋廣泛：擁有超過16,000種重組蛋白，涵蓋人類、小鼠、大鼠、兔、豚鼠、雞、猴、豬等多種物種的基因與靶點(diǎn)，支持跨物種比較研究。
- 表達(dá)系統(tǒng)全面：提供五大表達(dá)系統(tǒng)，包括大腸桿菌、酵母、桿狀病毒-昆蟲細(xì)胞、哺乳動(dòng)物細(xì)胞以及特有的無細(xì)胞表達(dá)系統(tǒng)。該系統(tǒng)省去質(zhì)粒轉(zhuǎn)化、細(xì)胞培養(yǎng)、破碎離心等步驟，顯著提升蛋白制備效率。
- 多標(biāo)簽選擇：支持His、GST、Flag、MBP等多種標(biāo)簽，便于后續(xù)純化、檢測與功能研究。
- 多領(lǐng)域應(yīng)用：適用于抗原制備、細(xì)胞與分析、蛋白互作、藥物研發(fā)、酶活性檢測、ELISA標(biāo)準(zhǔn)品、體內(nèi)外研究、質(zhì)譜與結(jié)構(gòu)分析等廣泛場景。
- 無動(dòng)物源成分：我們已建立全程無動(dòng)物副產(chǎn)品接觸的重組蛋白生產(chǎn)線，確保產(chǎn)品的高純凈性與一致性，適用于對來源敏感的各類實(shí)驗(yàn)。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì)，或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的重組蛋白，請查看華美生物蛋白定制服務(wù)。
通過選擇目標(biāo)名稱的首字母瀏覽產(chǎn)品。
| 產(chǎn)品名稱 | 貨號(hào) | 規(guī)格 |
|---|---|---|
| Recombinant Haemophilus influenzae D-xylose-binding periplasmic protein (xylF) | CSB-YP338044HTA CSB-EP338044HTA CSB-BP338044HTA CSB-MP338044HTA CSB-EP338044HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Competence protein ComM (comM), partial | CSB-YP338045HTA CSB-EP338045HTA CSB-BP338045HTA CSB-MP338045HTA CSB-EP338045HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Oligopeptide transport ATP-binding protein OppF (oppF) | CSB-YP338046HTA CSB-EP338046HTA CSB-BP338046HTA CSB-MP338046HTA CSB-EP338046HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Oligopeptide transport system permease protein oppC (oppC), partial | CSB-YP338047HTA1 CSB-EP338047HTA1 CSB-BP338047HTA1 CSB-MP338047HTA1 CSB-EP338047HTA1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Ribosomal RNA small subunit methyltransferase H (rsmH) | CSB-YP338048HTA CSB-EP338048HTA CSB-BP338048HTA CSB-MP338048HTA CSB-EP338048HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Peptidoglycan synthase FtsI (ftsI), partial | CSB-YP338049HTA CSB-EP338049HTA CSB-BP338049HTA CSB-MP338049HTA CSB-EP338049HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF) | CSB-YP338050HTA CSB-EP338050HTA CSB-BP338050HTA CSB-MP338050HTA CSB-EP338050HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial | CSB-YP338051HTA CSB-EP338051HTA CSB-BP338051HTA CSB-MP338051HTA CSB-EP338051HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Lipid II flippase FtsW (ftsW), partial | CSB-YP338052HTA CSB-EP338052HTA CSB-BP338052HTA CSB-MP338052HTA CSB-EP338052HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase | CSB-YP338053HTA CSB-EP338053HTA CSB-BP338053HTA CSB-MP338053HTA CSB-EP338053HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Cell division protein FtsQ (ftsQ), partial | CSB-YP338054HTA CSB-EP338054HTA CSB-BP338054HTA CSB-MP338054HTA CSB-EP338054HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Cell division protein FtsA (ftsA) | CSB-YP338055HTA CSB-EP338055HTA CSB-BP338055HTA CSB-MP338055HTA CSB-EP338055HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae UPF0042 nucleotide-binding protein HI_1146 (HI_1146) | CSB-YP338056HTA CSB-EP338056HTA CSB-BP338056HTA CSB-MP338056HTA CSB-EP338056HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Lipopolysaccharide export system ATP-binding protein LptB (lptB) | CSB-YP338057HTA CSB-EP338057HTA CSB-BP338057HTA CSB-MP338057HTA CSB-EP338057HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Lipopolysaccharide export system protein lptC (lptC), partial | CSB-YP338058HTA1 CSB-EP338058HTA1 CSB-BP338058HTA1 CSB-MP338058HTA1 CSB-EP338058HTA1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Hypoxanthine phosphoribosyltransferase (hpt) | CSB-YP338059HTA CSB-EP338059HTA CSB-BP338059HTA CSB-MP338059HTA CSB-EP338059HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Anaerobic ribonucleoside-triphosphate reductase-activating protein (nrdG) | CSB-YP338060HTA CSB-EP338060HTA CSB-BP338060HTA CSB-MP338060HTA CSB-EP338060HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae ATP-binding/permease protein CydD (cydD), partial | CSB-YP338061HTA1 CSB-EP338061HTA1 CSB-BP338061HTA1 CSB-MP338061HTA1 CSB-EP338061HTA1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Putative esterase HI_1161 (HI_1161) | CSB-YP338062HTA CSB-EP338062HTA CSB-BP338062HTA CSB-MP338062HTA CSB-EP338062HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Haemophilus influenzae Protein opa (opa) | CSB-YP338063HTA CSB-EP338063HTA CSB-BP338063HTA CSB-MP338063HTA CSB-EP338063HTA-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用資源
什么是重組蛋白?
重組蛋白是一種可操縱的蛋白質(zhì)形式，可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中，除了表達(dá)系統(tǒng)之外，還面臨著一系列令人困惑的選擇，如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí)，你必須做出很多決定。如果你選擇的明智，你將獲得高質(zhì)量的重組蛋白，后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定，你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里，來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示，可以幫助你做出明智的決策。
第一條：重組蛋白的生產(chǎn)，在這篇文章中，我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。
第二條：如何選擇合適的表達(dá)載體?
表達(dá)載體是一種DNA分子，它攜帶特定的基因進(jìn)入宿主細(xì)胞，并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá)，經(jīng)過多年的發(fā)展，表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示，本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。
根據(jù)重組蛋白的不同應(yīng)用，對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題，并提供一些解決方案。除了以上文章，我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外，我們還為我們的客戶提供重組蛋白表達(dá)服務(wù)，您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問，涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等，您可以點(diǎn)擊橙色按鈕為我們在線留言。
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022
